Literature DB >> 18277030

Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis.

Yuko Makino1, Yuri Shimanuki, Noriko Fujiwara, Yoshiteru Morio, Koichi Sato, Jiro Yoshimoto, Yoko Gunji, Tsutomu Suzuki, Shin-ichi Sasaki, Akihiko Iwase, Seiji Kawasaki, Kazuhisa Takahashi, Kuniaki Seyama.   

Abstract

A 38-year-old woman was admitted due to lymphangioleiomyomatosis (LAM)-associated massive chylous ascites and progressive cachexia. She was incidentally diagnosed to have ascites during her regular physical check-up two years previously and LAM was revealed as its underlying cause. Periodic paracentesis was required to ameliorate ascites-associated symptoms, but resulted in lymphocytopenia, malnutrition, and deterioration of general status. Ascites was refractory to diuretics and fat-restricted diet. Peritoneovenous shunt (Denver shunt) was placed and thereafter ascites has been managed successfully without any complications for one year after the placement. Peritoneovenous shunt should be considered in LAM patients whose chylous ascites can not be managed with conservative treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18277030     DOI: 10.2169/internalmedicine.47.0475

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

1.  Peritoneovenous shunt for intractable ascites due to hepatic lymphorrhea after hepatectomy.

Authors:  Yoshihiro Inoue; Michihiro Hayashi; Fumitoshi Hirokawa; Atsushi Takeshita; Nobuhiko Tanigawa
Journal:  World J Gastrointest Surg       Date:  2011-01-27

2.  Laparoscopic management of chylous ascites following laparoscopic donor nephrectomy.

Authors:  Ashish Sinha; Nizam Mamode
Journal:  BMJ Case Rep       Date:  2010-01-13

3.  Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients.

Authors:  Hooman Yarmohammadi; Lynn A Brody; Joseph P Erinjeri; Anne M Covey; F Edward Boas; Etay Ziv; Majid Maybody; Adrian J Gonzalez-Aguirre; Karen T Brown; Joel Sheinfeld; George I Getrajdman
Journal:  J Vasc Interv Radiol       Date:  2016-03-07       Impact factor: 3.464

Review 4.  Incidence and risk factors for Chyle leak after pancreatic surgery for cancer: A comprehensive systematic review.

Authors:  Milena Muzzolini; Raphael L C Araujo; T Peter Kingham; Frédérique Peschaud; François Paye; Renato M Lupinacci
Journal:  Eur J Surg Oncol       Date:  2021-12-03       Impact factor: 4.424

Review 5.  Chylous Ascites and Lymphoceles: Evaluation and Interventions.

Authors:  Ernesto Santos; Amgad M Moussa
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

6.  Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going.

Authors:  Angelo M Taveira-Dasilva; Wendy K Steagall; Joel Moss
Journal:  F1000 Med Rep       Date:  2009-12-09

7.  Treatment of Chylous Ascites with Peritoneovenous Shunt (Denver Shunt) following Retroperitoneal Lymph Node Dissection in Patients with Urological Malignancies: Update of Efficacy and Predictors of Complications.

Authors:  Hooman Yarmohammadi; Juliana Schilsky; Jeremy C Durack; Lynn A Brody; Ulrika Asenbaum; Sara Velayati; Ernesto Santos; Adrian J Gonzalez-Aguirre; Joseph P Erinjeri; Nadia Petre; Stephen B Solomon; Joel Sheinfeld; George I Getrajdman
Journal:  J Urol       Date:  2020-05-05       Impact factor: 7.600

Review 8.  Management of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  F1000Prime Rep       Date:  2014-12-01

Review 9.  Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.

Authors:  Richa Bhardwaj; Haleh Vaziri; Arun Gautam; Enrique Ballesteros; David Karimeddini; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-12-04

10.  Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus.

Authors:  Takahiko Sakaue; Masaki Tominaga; Takashi Niizeki; Yoshiaki Zaizen; Ken Matsukuma; Masamichi Koganemaru; Tomoaki Hoshino; Takuji Torimura
Journal:  Respir Med Case Rep       Date:  2018-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.